Fact-checked by Grok 2 weeks ago

Ischemia

Ischemia is a serious medical condition characterized by restricted blood flow to an organ or tissue, leading to a deficiency of oxygen and nutrients essential for cellular function.^[1] This hypoperfusion typically arises from pathologic constriction, obstruction of blood vessels, or reduced blood supply, potentially causing tissue damage or necrosis if prolonged. Common in various body parts, ischemia can manifest acutely or chronically and is a leading contributor to life-threatening events such as heart attacks and strokes.^[1] The primary causes of ischemia include atherosclerosis, where plaque buildup narrows arteries; blood clots (thrombosis or embolism) that block vessels; and conditions like low blood pressure, vasculitis, or external compression.^[1] Risk factors encompass modifiable elements such as smoking, high cholesterol, diabetes, hypertension, and obesity, alongside non-modifiable ones like age, family history, and genetic predispositions.^[2] In the United States, heart disease—often driven by ischemia—remains the top cause of death, while globally over 200 million people live with peripheral artery disease, a form of ischemic condition (as of 2024).^[1] In the United States, a stroke—frequently ischemic in nature—occurs every 40 seconds; worldwide, over 12 million people experience a new stroke each year (as of 2024).^[1]^[3] Symptoms of ischemia vary by the affected area but often include pain, weakness, or dysfunction in the involved tissue; for instance, chest pain (angina) in cardiac ischemia, sudden numbness or confusion in cerebral ischemia, or abdominal cramping in intestinal cases.^[1] Some instances, known as silent ischemia, may present without noticeable symptoms, particularly in the heart, increasing undetected risk.^[2] Types encompass myocardial (heart), cerebral (brain, as in ischemic stroke or transient ischemic attack), peripheral (limbs), mesenteric (intestines), and renal (kidneys), each with potentially severe complications like infarction if blood flow is not restored promptly.^[1]^[4] Diagnosis typically involves physical examination, imaging such as ultrasound, CT angiography, or MRI, and functional tests like electrocardiography (ECG) for cardiac cases to assess blood flow and tissue viability.^[1] Treatment focuses on restoring perfusion through medications (e.g., antiplatelets, thrombolytics, or vasodilators), lifestyle modifications (e.g., diet, exercise, smoking cessation), or interventions like angioplasty, stenting, or bypass surgery.^[1] Prevention emphasizes managing risk factors, with regular screening recommended for high-risk individuals to mitigate progression to irreversible damage.^[2]

Definition and Classification

Definition

Ischemia is defined as an inadequate blood supply to a local area of tissue or an organ, resulting from obstruction, reduction, or impairment in blood flow or circulation, which deprives cells of essential oxygen and nutrients.^[4] This imbalance between oxygen supply and metabolic demand can impair cellular function but does not necessarily cause immediate tissue death.^[5] Arterial blood flow is the primary physiological mechanism for oxygen delivery to tissues, with oxygen transported mainly bound to hemoglobin in erythrocytes and released via diffusion across concentration gradients to meet cellular needs.^[6] Reduced perfusion disrupts this process, leading to accumulation of metabolic byproducts and potential cellular injury if prolonged.^[7] As a consequence, ischemia often results in tissue hypoxia, where oxygen levels fall below those required for aerobic metabolism.^[8] The term "ischemia," derived from the Greek roots isch- (restriction) and -haima (blood), entered medical literature to describe circulatory deficits and gained prominence in early 20th-century physiology through studies on vascular pathology and tissue responses to reduced perfusion.^[9] A key distinction exists between ischemia and infarction: while ischemia represents a potentially reversible state of oxygen deprivation if blood flow is restored within a critical timeframe (typically 20-30 minutes for myocardial tissue), infarction denotes irreversible necrosis due to sustained ischemia beyond this window.^[10]^[11]

Types

Ischemia is classified based on duration, extent of involvement, potential for reversibility, etiology, and the affected organ system, providing a framework for diagnosis and management. Based on duration, ischemia is divided into acute and chronic forms. Acute ischemia arises suddenly, typically over minutes to hours, often triggered by abrupt events such as arterial embolism or thrombosis that severely restrict blood flow.^[1] In contrast, chronic ischemia develops gradually, usually over months to years, due to progressive narrowing of arteries from conditions like atherosclerosis.^[1] Regarding extent of involvement, ischemia is categorized as focal or global. Focal ischemia affects a specific vascular territory or organ region, commonly resulting from localized vessel occlusion.^[1] Global ischemia, however, involves widespread hypoperfusion across multiple organs or the entire body, often stemming from systemic conditions like severe hypotension or cardiogenic shock.^[1] The reversibility of ischemia depends primarily on its duration and the adequacy of collateral circulation. The reversibility of ischemic changes depends on duration, tissue type, and collateral circulation. For example, in myocardial tissue, changes are typically reversible for approximately 20–40 minutes following complete occlusion, but the timeframe is shorter for neuronal tissue (often minutes) and longer for other organs like the kidney; after which reperfusion can restore function without permanent damage. Prolonged ischemia beyond this window leads to irreversible tissue injury and necrosis, though well-developed collateral vessels can extend the viable period by providing alternative perfusion pathways.^[12]^[13]^[14] Etiologically, ischemia is often classified as occlusive or non-occlusive. Occlusive ischemia results from mechanical blockage of vessels, such as thrombosis in preexisting atherosclerotic plaques or embolization from distant sources.^[15] Non-occlusive ischemia occurs without vessel obstruction, driven instead by reduced perfusion pressure from factors like hypovolemia, heart failure, or vasoconstriction.^[15] Classification by affected organ system highlights site-specific variations, including myocardial ischemia of the heart, cerebral ischemia of the brain, mesenteric ischemia of the intestines, peripheral ischemia of the limbs, renal ischemia of the kidneys, and cutaneous ischemia of the skin.^[1] For instance, myocardial ischemia frequently manifests in coronary arteries, while cerebral ischemia commonly involves major intracranial vessels.^[1]

Epidemiology

Global Burden

Ischemia, particularly in the form of ischemic heart disease (IHD) and ischemic stroke, imposes a substantial global health burden, with IHD affecting approximately 254 million cases worldwide in 2021.^[16] This prevalence underscores IHD as a leading contributor to cardiovascular morbidity, driven by factors such as atherosclerosis and thrombosis. Projections indicate a 90% increase in overall cardiovascular disease prevalence by 2050, reflecting demographic shifts including population growth and aging.^[17] Ischemic stroke ranks as the third-largest cause of disability-adjusted life years (DALYs) globally in 2023 among cardiovascular diseases, highlighting its role in long-term disability and mortality.^[18] In 2021, acute ischemic stroke accounted for around 70 million cases, contributing to over 10 million incident strokes annually and exacerbating the global disease burden through recurrent events and complications.^[19] These figures emphasize the acute and chronic impacts, with ischemic stroke responsible for significant years of healthy life lost. The burden disproportionately affects low- and middle-income countries (LMICs), where approximately 80% of cardiovascular deaths occur, amplified by rapid aging populations and limited access to preventive care.^[20] In these regions, the interplay of demographic transitions and socioeconomic challenges leads to higher age-adjusted rates of ischemia-related morbidity compared to high-income settings.^[21] In LMICs, these expenses strain health systems, often exceeding per capita public health expenditures, while in high-income countries, indirect costs from workforce absenteeism further compound the impact.^[22]

Risk Factors

Risk factors for ischemia can be categorized as non-modifiable or modifiable, with emerging factors also contributing to susceptibility across various ischemic conditions such as coronary artery disease and stroke. Non-modifiable factors include advancing age, where the risk of ischemic stroke approximately doubles every decade after age 55, reflecting cumulative vascular wear and reduced physiological reserve.^[23] Male sex is associated with higher incidence of ischemic heart disease and stroke, particularly in younger adults, due to differences in hormonal influences and vascular biology.^[24] Family history of premature cardiovascular disease elevates risk through shared genetic and environmental exposures, with first-degree relatives of affected individuals showing up to a twofold increase in ischemic events.^[25] Genetic predispositions, such as the factor V Leiden mutation, further heighten thrombotic tendencies, increasing the odds of ischemic stroke by 1.5- to 2-fold in carriers, especially in those with additional triggers like oral contraceptives.^[26] Modifiable risk factors predominate in the etiology of ischemia and offer substantial opportunities for prevention. Hypertension stands out as a leading contributor, accounting for approximately 50% of ischemic strokes globally through endothelial damage and accelerated atherosclerosis.^[27] Diabetes mellitus impairs vascular integrity via hyperglycemia-induced inflammation and microangiopathy, doubling the risk of ischemic events independent of other comorbidities.^[25] Hyperlipidemia promotes plaque formation in arteries, with elevated low-density lipoprotein cholesterol raising ischemic heart disease risk by 2- to 3-fold.^[24] Smoking accelerates endothelial dysfunction and thrombosis, contributing to 10-20% of ischemic strokes via oxidative stress and platelet activation.^[25] Obesity, particularly central adiposity, fosters insulin resistance and inflammation, increasing susceptibility to ischemia by 1.5- to 2-fold.^[24] Emerging factors, including air pollution and metabolic syndrome, are gaining recognition for their role in ischemia, as highlighted in recent analyses. Ambient fine particulate matter exposure elevates stroke risk by 5-10% per 10 μg/m³ increase, through systemic inflammation and autonomic imbalance, with WHO data underscoring its contribution to noncommunicable diseases including ischemic events.^[28] Metabolic syndrome, characterized by the clustering of hypertension, dyslipidemia, obesity, and insulin resistance, amplifies overall cardiovascular risk by 2-fold, as per updated global health assessments.^[29] Interactions among risk factors often produce synergistic effects, magnifying ischemic vulnerability. For instance, the coexistence of hypertension and diabetes can increase stroke risk up to 4-fold compared to either condition alone, due to compounded vascular remodeling and prothrombotic states.^[30]

Clinical Manifestations

Cardiac Ischemia

Cardiac ischemia, also known as myocardial ischemia, occurs when blood flow to the heart muscle is reduced, leading to oxygen deprivation that manifests primarily through symptoms affecting cardiac function.^[31] The hallmark symptom is angina pectoris, characterized by substernal chest pain or discomfort that often radiates to the arms, jaw, neck, or back, typically triggered by exertion or stress and relieved by rest.^[32] Accompanying symptoms frequently include shortness of breath, fatigue, nausea, and sweating, which arise due to the heart's impaired ability to meet metabolic demands during ischemia.^[33] Unstable angina represents a more severe form of cardiac ischemia, distinguished by a crescendo pattern where episodes of chest pain increase in frequency, duration, or severity, often occurring at rest or with minimal provocation.^[31] Physical signs during acute episodes may include diaphoresis and pallor, reflecting autonomic activation and systemic hypoperfusion, while auscultation can reveal an S4 heart sound due to atrial contraction against a stiff ventricle.^[34] In some cases, prodromal symptoms such as escalating fatigue or intermittent chest discomfort may worsen over days preceding an acute coronary syndrome event, serving as early indicators of impending instability.^[35] A notable variant is silent ischemia, where myocardial oxygen deprivation occurs without typical anginal pain, particularly prevalent in patients with diabetes due to autonomic neuropathy impairing pain perception; this affects more than one in five asymptomatic individuals with type 2 diabetes.^[36] Such silent episodes underscore the importance of recognizing atypical presentations in high-risk groups, as they can progress undetected to more severe cardiac events.^[37]

Cerebral Ischemia

Cerebral ischemia occurs when blood flow to the brain is insufficient, depriving neural tissue of oxygen and nutrients, which can result in acute neurological deficits. This condition primarily presents as ischemic stroke, characterized by sudden onset of focal neurological impairments, or as a transient ischemic attack (TIA), a temporary episode of similar symptoms. Common symptoms include sudden weakness or hemiparesis, typically affecting one side of the body; aphasia or difficulty with speech and comprehension; visual field loss in one or both eyes; and vertigo or dizziness.^[38]^[39] Physical signs of cerebral ischemia often include facial droop on one side, altered levels of consciousness ranging from confusion to coma, and ataxia or impaired coordination. These manifestations arise from the brain's vulnerability to even brief interruptions in perfusion, leading to rapid cellular dysfunction. In TIA, symptoms mirror those of stroke but fully resolve within 24 hours, often within minutes, without leaving permanent damage, though it signals a high risk for subsequent stroke.^[40]^[41] The specific symptoms depend on the affected vascular territory. Ischemia in the anterior circulation, supplied by the carotid arteries, commonly causes motor and sensory deficits such as hemiparesis and aphasia due to involvement of the cerebral hemispheres. In contrast, posterior circulation ischemia, involving the vertebral and basilar arteries, more frequently leads to visual disturbances, vertigo, and equilibrium issues from brainstem and cerebellar involvement.^[42]^[43] Silent cerebral ischemia refers to subclinical episodes detected incidentally on neuroimaging, such as MRI, without overt symptoms, and is prevalent in older adults. These silent infarcts are associated with a doubled risk of developing dementia and accelerated cognitive decline, independent of other vascular risk factors. Conditions like atrial fibrillation, a common arrhythmia, heighten the risk of cerebral ischemia by promoting thromboembolic events.^[44]^[45]

Mesenteric Ischemia

Mesenteric ischemia refers to the compromise of blood supply to the intestines, primarily affecting the small bowel and colon, leading to tissue hypoperfusion and potential infarction. In acute forms, patients typically present with severe, diffuse abdominal pain that is out of proportion to physical examination findings, often described as periumbilical or epigastric in location and sudden in onset.^[46]^[47]^[48] Accompanying symptoms include nausea and vomiting, which may become bloody in advanced stages due to mucosal sloughing and bowel wall necrosis.^[48]^[47] Physical signs in acute mesenteric ischemia are often unremarkable early on, with only mild abdominal distension or tenderness noted, but progression leads to peritoneal irritation manifested as guarding, rebound tenderness, and absent or hypoactive bowel sounds in late stages indicative of infarction.^[46]^[48] In contrast, chronic mesenteric ischemia develops gradually from progressive arterial stenosis, resulting in postprandial abdominal pain—often termed "intestinal angina"—that lasts 1 to 3 hours after eating and prompts food avoidance, leading to significant unintentional weight loss.^[47]^[46] Diarrhea may occur in both acute and chronic cases, but it is more chronic and less severe in the latter.^[47] Among acute cases, embolic occlusion accounts for approximately 50% and presents with abrupt, severe pain due to sudden blockage, often from cardiac sources such as atrial fibrillation.^[46]^[48] Thrombotic occlusion, comprising 15% to 25% of cases, typically features a more insidious onset with pain exacerbated postprandially, stemming from in-situ clot formation on atherosclerotic plaques.^[47]^[48] These distinctions highlight the rapid decompensation in embolic events compared to the potentially more gradual progression in thrombotic ones.^[46]

Limb Ischemia

Limb ischemia refers to reduced blood flow to the extremities, primarily the arms or legs, resulting from arterial insufficiency, which can manifest as acute or chronic forms depending on the onset and duration of the occlusion.^[49] In chronic limb ischemia, patients typically experience intermittent claudication, characterized by muscle pain or cramping in the affected limb during exertion, such as walking, which resolves with rest due to inadequate perfusion during increased demand.^[49] As the condition progresses to critical limb ischemia, rest pain emerges, often described as a burning or aching sensation in the foot or toes that worsens when the limb is elevated and improves with dependency, alongside potential tissue loss.^[50] Physical signs in chronic limb ischemia include pallor of the skin upon elevation, coolness to the touch, and diminished or absent peripheral pulses, reflecting ongoing hypoperfusion.^[51] Advanced stages may show ulceration, particularly over pressure points like the toes or lateral malleolus, and gangrene due to tissue necrosis from prolonged ischemia.^[52] Chronic changes also encompass hair loss on the affected limb, brittle or thickened nails, and shiny, taut skin, indicating long-term vascular compromise.^[51] Acute limb ischemia presents abruptly with severe, sudden pain in the extremity, often following embolic or thrombotic events, and requires immediate intervention to prevent irreversible damage.^[53] The classic clinical features, known as the "six P's," include pain, pallor, pulselessness, paresthesia (sensory alterations like numbness or tingling), paralysis (motor weakness or loss), and poikilothermy (the limb feeling cooler than the contralateral side).^[54] Additional symptoms may involve hypesthesia and weakness, with progression to muscle contracture and purpura if untreated.^[53] Traumatic causes, such as arterial dissection, can precipitate acute episodes but are detailed elsewhere in the etiology of ischemia.^[51]

Cutaneous Ischemia

Cutaneous ischemia refers to reduced blood flow to the skin, resulting in oxygen deprivation that manifests primarily in the dermis and epidermis. This condition often arises from local vascular compromise or systemic factors affecting dermal perfusion, leading to distinctive dermatological changes. Unlike deeper tissue ischemia, cutaneous involvement is characterized by superficial alterations that can progress if perfusion is not restored. Symptoms of cutaneous ischemia typically include pain in the affected skin areas, which is often exacerbated at pressure points such as the heels, sacrum, or elbows due to sustained compression occluding microvasculature. This ischemic pain arises from tissue hypoxia and can be described as burning or aching, particularly in immobile patients or those with underlying vascular disease.^[55] Visible signs include livedo reticularis, a mottled, net-like pattern of reddish-blue discoloration caused by sluggish blood flow in dermal vessels, and cyanosis, a bluish tint indicating deoxygenated hemoglobin accumulation in the skin. Non-healing ulcers are another hallmark, presenting as punched-out lesions with pale or necrotic bases that fail to granulate due to persistent hypoperfusion.^[56]^[57] Specific conditions associated with cutaneous ischemia include Raynaud's phenomenon, a vasospastic disorder causing episodic digital ischemia triggered by cold or stress, resulting in triphasic color changes (pallor, cyanosis, rubor) and sensory symptoms like numbness or tingling. In systemic sclerosis (scleroderma), digital ischemia frequently leads to recurrent ulcers on the fingertips, driven by vasculopathy with endothelial damage and intimal proliferation.^[58]^[59] Necrosis in cutaneous ischemia progresses from initial mottling, reflecting early vasomotor instability, to persistent cyanosis and ulceration as hypoxic damage accumulates. If untreated, this advances to full-thickness skin loss, with eschar formation and potential sloughing of devitalized tissue, increasing infection risk. Systemic causes such as vasculitis may contribute to these manifestations.^[60]^[61]

Renal Ischemia

Renal ischemia refers to reduced blood flow to the kidneys, often resulting from hypoperfusion due to systemic hypotension, renal artery stenosis, or embolism, leading to acute or chronic kidney dysfunction.^[62] In acute settings, such as post-stenotic ischemia in renal artery stenosis, patients may experience sudden oliguria or anuria as the kidneys fail to maintain adequate glomerular filtration, alongside flank pain from tissue injury or infarction.^[63] Hematuria, ranging from microscopic to gross, can occur particularly in cases of renal infarction or acute tubular necrosis following ischemic insult, reflecting damage to the renal parenchyma.^[64] Clinically, signs of renal ischemia include elevated blood pressure, often refractory and treatment-resistant in the context of bilateral renal artery stenosis, as the juxtaglomerular apparatus releases excess renin.^[63] Edema may develop due to sodium and water retention from acute kidney injury, contributing to systemic fluid overload.^[62] In chronic ischemic nephropathy, progressive renal failure manifests as a persistent decline in glomerular filtration rate and unexplained rises in blood urea nitrogen, without prominent acute symptoms but with gradual worsening of kidney function.^[63] Cardiorenal syndrome exemplifies the interplay of ischemia between heart and kidney, where acute cardiac decompensation reduces renal perfusion, causing hypoperfusion and injury; type 1 syndrome specifically involves acute heart failure precipitating acute kidney injury with oliguric features.^[65] A rise in serum creatinine serves as a key biomarker indicating the extent of renal dysfunction in these scenarios.^[62]

Other Sites

Ischemia affecting the spleen, often termed splenic infarction, typically presents with acute left upper quadrant abdominal pain and tenderness, which may radiate to the left flank or shoulder. This condition is frequently associated with underlying hematologic disorders, hypercoagulable states, or malignancies, and physical examination may reveal signs of hypersplenism such as splenomegaly or thrombocytopenia in predisposed patients. Diagnosis is supported by imaging showing wedge-shaped hypodense areas on computed tomography, and management focuses on treating the underlying cause to prevent complications like abscess formation.^[66]^[67] Pancreatic ischemia is a rare form of acute pancreatitis mimicry, characterized by sudden epigastric pain radiating to the back, accompanied by nausea, vomiting, and elevated serum amylase levels. It arises from hypoperfusion due to systemic shock or vascular occlusion, distinguishing it from more common gallstone or alcohol-related pancreatitis through context of hemodynamic instability. Clinical severity varies from mild reversible injury to fulminant necrosis, necessitating prompt vascular assessment and supportive care.^[68]^[69] Retinal ischemia commonly manifests as sudden, painless monocular vision loss, known as amaurosis fugax when transient, or profound visual impairment in cases of central retinal artery occlusion. Fundoscopic examination reveals a characteristic cherry-red spot at the macula amid retinal whitening due to inner retinal edema, with attenuated vessels indicating vascular compromise. This embolic or thrombotic event requires urgent evaluation for carotid artery disease to mitigate stroke risk.^[70]^[71] Ocular ischemia beyond the retina, such as in ocular ischemic syndrome, often involves transient monocular vision loss triggered by posture changes or bright light, alongside gradual visual decline and orbital pain. Gonadal ischemia, primarily from torsion, presents with acute, severe unilateral testicular or pelvic pain in males and females, respectively, often with nausea and scrotal or adnexal swelling. These rare presentations demand rapid surgical intervention to restore perfusion and preserve organ viability.^[72]^[73]^[74]

Causes

Occlusive Causes

Occlusive causes represent the predominant etiology of ischemia, arising from the blockage or narrowing of blood vessels that impedes perfusion to downstream tissues. These mechanisms primarily involve intrinsic vascular obstructions that reduce or halt blood flow, distinguishing them from extrinsic or traumatic insults. Among occlusive processes, thrombosis, embolism, and vasospasm are the key contributors, each driven by distinct pathophysiological pathways that culminate in acute or chronic ischemia across various vascular beds, such as coronary, cerebral, and peripheral arteries.^[75] Thrombosis occurs through the in situ formation of a blood clot within a vessel, most commonly triggered by the rupture of an atherosclerotic plaque, which exposes thrombogenic subendothelial components and activates the coagulation cascade. In coronary ischemia, atherosclerosis underlies approximately 80% of cases, where plaque disruption leads to occlusive thrombus formation, precipitating acute myocardial infarction. Plaque composition plays a critical role in vulnerability; plaques with a thin fibrous cap, large necrotic core, and high lipid content are prone to rupture under mechanical stress, promoting thrombosis. Additionally, hemodynamic factors like elevated wall shear stress at plaque shoulders exacerbate fissure formation, accelerating occlusion.^[76]^[77]^[78]^[79] Embolism involves the dislodgement of material that travels to and occludes a distant vessel, often originating from the heart in conditions like atrial fibrillation, where thrombi form in the left atrial appendage and embolize to systemic arteries, causing ischemia in cerebral or limb territories. Paradoxical embolism, a rarer variant, occurs when venous thrombi bypass the pulmonary circulation via a patent foramen ovale (PFO), entering the arterial system and inducing ischemia, such as acute limb or coronary occlusion. These events typically present abruptly, with embolic material lodging at bifurcations or narrowed segments, leading to rapid downstream hypoperfusion.^[80]^[75]^[81] Vasospasm manifests as transient, intense constriction of vascular smooth muscle, temporarily occluding the lumen without structural damage, and is exemplified by coronary vasospasm in Prinzmetal's angina, where episodic spasms provoke myocardial ischemia at rest, often with ST-segment elevation on ECG. This condition arises from endothelial dysfunction and hyperreactivity to vasoconstrictors like endothelin, independent of fixed atherosclerosis in many cases. While less common than thrombotic or embolic occlusion, vasospasm can precipitate recurrent ischemic episodes and, if severe, evolve into infarction.^[82]^[83]

Traumatic Causes

Traumatic causes of ischemia arise from physical injuries that directly or indirectly compromise blood flow to tissues, often leading to acute and potentially reversible deficits if addressed promptly. These injuries can involve mechanical disruption of vessels or surrounding structures, resulting in localized or systemic hypoperfusion. Unlike occlusive causes driven by endogenous processes, traumatic ischemia stems from external forces such as blunt or penetrating impacts, which may necessitate urgent surgical intervention to restore perfusion.^[84] Direct trauma to blood vessels, such as lacerations from penetrating injuries like stab wounds or gunshots, can cause complete transection or partial wall defects, halting arterial flow and inducing downstream ischemia. For instance, injuries to major arteries like the femoral or popliteal vessels, which account for 50-60% of traumatic arterial cases, disrupt blood supply and may lead to limb-threatening hypoperfusion if not repaired swiftly. Compression from swelling or external pressure, as seen in compartment syndrome following fractures (of which approximately 75% of cases are associated with fractures overall, with tibial shaft fractures being the most common cause, accounting for about 36-40%), elevates intracompartmental pressure above capillary perfusion thresholds (typically >30 mmHg), impairing venous outflow and arterial inflow to cause muscle and nerve ischemia. This mechanism is exacerbated post-fracture by hemorrhage and edema within the closed fascial spaces, potentially progressing to necrosis if fasciotomy is delayed beyond 6 hours.^[84]^[85] Iatrogenic traumatic ischemia occurs as a complication of medical procedures, including accidental vessel ligation during surgery or occlusion from catheterization devices. Post-surgical ligation of unintended arteries, such as in abdominal or pelvic operations, can reduce regional blood flow and cause organ-specific ischemia, with vascular injuries reported as rare (typically <0.5%) in elective cases. Similarly, percutaneous interventions like angiography carry a 0.8-1.8% risk of complications such as thrombosis or embolization, where closure devices may obstruct the femoral artery, leading to acute limb ischemia; these events often require thrombolysis or surgical embolectomy for resolution.^[86]^[87] Indirect trauma, particularly hypovolemic shock from hemorrhage, diminishes circulating blood volume and cardiac output, broadly reducing tissue perfusion and causing ischemia across multiple organs. In traumatic scenarios, blood loss exceeding 20-25% of total volume overwhelms compensatory vasoconstriction, leading to anaerobic metabolism, lactic acidosis, and end-organ hypoperfusion; this is compounded by trauma-induced capillary leakage, further depleting intravascular volume.^[88]^[89] Upon resolution of traumatic ischemia through revascularization or fluid resuscitation, reperfusion injury poses a significant risk, paradoxically amplifying tissue damage via oxidative stress and inflammation. This process involves reactive oxygen species production and neutrophil activation upon blood flow restoration, potentially leading to edema, compartment syndrome, or multi-organ dysfunction in severe cases like prolonged limb ischemia.^[90]

Other Etiologies

Hypoperfusion, a systemic reduction in blood flow, represents a non-occlusive cause of ischemia that impairs oxygen delivery to tissues across multiple organs. In cardiogenic shock, a primary cardiac disorder characterized by low cardiac output, end-organ hypoperfusion and tissue hypoxia occur due to impaired left ventricular function, often perpetuated by a vicious cycle of ongoing myocardial ischemia and compensatory vasoconstriction that increases afterload.^[91] Sepsis contributes to hypoperfusion through profound hypotension and vasodilation, leading to reduced organ perfusion and ischemic changes, such as hypoenhancement of the liver and spleen on imaging.^[92] Dehydration-induced hypovolemia depletes intravascular volume, resulting in inadequate tissue perfusion, hypoxia, and potential progression to organ dysfunction if untreated.^[88] Vasculitis involves inflammatory processes that cause arterial narrowing and stenosis, distinct from mechanical occlusion, thereby inducing ischemia in affected vascular beds. Takayasu arteritis, a granulomatous large-vessel vasculitis targeting the aorta and its branches, leads to transmural fibrous thickening of arterial walls, resulting in stenoses that reduce blood flow and cause ischemic manifestations such as renovascular hypertension, upper extremity claudication, and cerebrovascular events.^[93]^[94] Hypercoagulable states promote thrombosis without direct vessel occlusion, fostering a prothrombotic environment that culminates in ischemic events. Antiphospholipid syndrome, an autoimmune disorder marked by antiphospholipid antibodies, induces a hypercoagulable state through mechanisms including upregulated tissue factor expression on endothelial cells and monocytes, complement activation, and impaired fibrinolysis, leading to arterial and venous thromboses that cause ischemia in organs like the brain and limbs.^[95]^[96] Rare etiologies include toxin-mediated or temperature-dependent vascular disruptions. Cold agglutinin disease, an autoimmune hemolytic anemia driven by IgM antibodies that agglutinate red blood cells at low temperatures (below 31°C), can precipitate microvascular occlusion and hypoperfusion, resulting in ischemic strokes, as evidenced by cases of acute cerebral infarction resolving with warming and immunosuppression.^[97] Ergotism, arising from ergot alkaloid exposure (e.g., via ergotamine for migraines), induces potent vasoconstriction of medium-sized arteries through serotonin receptor stimulation and direct smooth muscle contraction, causing peripheral limb ischemia, gangrene, and occasionally multiorgan involvement.^[98]^[99]

Pathophysiology

Cellular Mechanisms

Ischemia begins with oxygen deprivation to cells, which rapidly halts aerobic respiration in mitochondria and forces a metabolic shift to anaerobic glycolysis for ATP production.^[100] This anaerobic pathway is inefficient, yielding only 2 ATP molecules per glucose compared to 36 under aerobic conditions, and results in the accumulation of lactic acid as pyruvate is converted to lactate to regenerate NAD+.^[101] The buildup of lactic acid lowers intracellular pH, contributing to cellular acidosis that impairs enzymatic functions and exacerbates energy deficits.^[100] Within minutes of ischemia onset, ATP levels deplete dramatically—falling to critically low concentrations in as little as 15-20 minutes in cardiac tissue models—disrupting energy-dependent processes.^[100] This depletion primarily affects the Na+/K+ ATPase pump, which fails to maintain ionic gradients, leading to sodium accumulation inside the cell and subsequent depolarization.^[100] The resulting osmotic imbalance and membrane instability promote calcium influx through voltage-gated channels and reverse-mode sodium-calcium exchangers.^[100] Elevated cytosolic calcium triggers a cascade of destructive events, including the overactivation of calcium-dependent enzymes such as proteases, phospholipases, and endonucleases, which degrade cellular proteins, lipids, and DNA.^[102] Excessive calcium also accumulates in mitochondria, where it disrupts electron transport, impairs ATP synthesis, and induces permeability transition pore opening, leading to mitochondrial swelling and dysfunction.^[102] Upon reperfusion, the sudden restoration of oxygen generates oxidative stress through burst production of reactive oxygen species (ROS), primarily from mitochondrial electron transport chain leakage at complexes I and III, as well as xanthine oxidase activity converting accumulated substrates.^[103] These free radicals cause lipid peroxidation, protein oxidation, and DNA damage, amplifying cellular injury beyond the ischemic phase alone.^[103]

Tissue and Organ Response

Tissues subjected to ischemia initially attempt to adapt through mechanisms that reduce metabolic demand to preserve viability until blood flow is restored. One such adaptation is myocardial hibernation, a reversible downregulation of contractile function in response to chronic or repetitive ischemia, allowing the heart muscle to maintain viability despite reduced perfusion. This state is characterized by matched reductions in myocardial blood flow and function, preventing progression to irreversible damage. Similarly, myocardial stunning represents a transient post-ischemic contractile dysfunction that resolves upon reperfusion, without permanent cell loss, often following brief ischemic episodes. These adaptive responses highlight the tissue's capacity for short-term survival strategies during oxygen deprivation.^[104]^[105] If ischemia persists beyond the tissue's tolerance threshold, it progresses to infarction, marked by irreversible cell death due to prolonged energy failure. The timeline for infarction varies markedly by organ, reflecting differences in metabolic rates and oxygen dependence; for instance, brain neurons succumb within 4-6 minutes of complete ischemia, while cardiac myocytes withstand 20-30 minutes before irreversible injury sets in. This rapid progression in the brain underscores its vulnerability, where even brief interruptions can lead to widespread neuronal loss, whereas the heart exhibits greater resilience during acute events. Collateral circulation plays a crucial protective role, particularly in chronic ischemia, by providing alternative perfusion pathways; the Circle of Willis, for example, enables cross-flow between cerebral arteries, mitigating hypoperfusion in cases of arterial occlusion and improving outcomes in ischemic stroke.^[106] Organ-specific tolerances further illustrate these responses, with high-metabolic-demand tissues like the brain showing low ischemia tolerance compared to more resilient structures such as skin. Skin can endure ischemia for 6-12 hours before significant irreversible damage, owing to its lower baseline oxygen requirements and ability to tolerate anaerobic conditions, while skeletal muscle withstands 2-4 hours. In contrast, kidneys tolerate approximately 30-60 minutes of warm ischemia, and the liver up to 60-90 minutes, before infarction develops. These differences arise from variations in cellular composition, vascular density, and adaptive capacity, influencing clinical management across affected sites. As a foundational event, ischemia induces rapid ATP depletion in cells, impairing ion pumps and leading to the downstream tissue responses described here.^[106]

Diagnosis

Clinical Evaluation

Clinical evaluation of ischemia begins with a detailed history to assess the onset, characteristics, and context of symptoms, which are crucial for suspecting ischemic events across various organs. Sudden onset is a hallmark, particularly in acute cases like stroke or myocardial infarction, where symptoms often develop within minutes to hours.^[107] Pain quality varies by site; for instance, cardiac ischemia typically presents with crushing substernal chest pain radiating to the arm or jaw, exacerbated by exertion and relieved by rest or nitroglycerin, while limb ischemia may involve severe, unrelenting pain in the affected extremity.^[108] Risk factor assessment is integral, including queries about hypertension, diabetes mellitus, smoking, hyperlipidemia, atrial fibrillation, and family history of cardiovascular disease, as these increase susceptibility to occlusive ischemia.^[109] The physical examination focuses on vital signs and targeted organ assessments to identify signs of compromised perfusion. Tachycardia and hypotension may indicate compensatory responses to hypoperfusion or cardiogenic shock in systemic ischemia, while hypertension is common in early stroke presentations.^[109] Organ-specific findings include auscultation for carotid bruits suggesting cerebrovascular ischemia, absent or diminished pulses and cool skin in peripheral limb ischemia, or focal neurological deficits such as hemiparesis in cerebral events.^[110] In acute limb ischemia, the "six Ps" (pain, pallor, paresthesia, paralysis, poikilothermy, and pulselessness) guide viability assessment.^[110] Scoring tools aid in rapid stratification and guide further evaluation. The National Institutes of Health Stroke Scale (NIHSS) quantifies stroke severity through assessment of consciousness, motor function, and language, with scores ranging from 0 to 42; higher scores correlate with larger infarct territories.^[109] For suspected pulmonary embolism causing right heart ischemia, the Wells score evaluates pretest probability based on factors like clinical signs of deep vein thrombosis, heart rate over 100 bpm, and immobilization, categorizing risk as low, moderate, or high to inform diagnostic testing.^[111] Differential diagnosis is essential to distinguish ischemia from mimics, such as aortic dissection, which can present with similar acute chest or back pain but often involves tearing quality, unequal pulses, or neurological deficits due to branch vessel involvement.^[112] Symptoms vary by organ, as detailed in clinical manifestations, but bedside evaluation prioritizes ruling out life-threatening alternatives through history and exam alone.^[107]

Imaging Modalities

Duplex ultrasonography is a non-invasive first-line imaging modality for evaluating peripheral artery disease and carotid artery stenosis in ischemia. It combines B-mode imaging with Doppler to assess blood flow velocity, stenosis severity, and plaque characteristics, offering high accuracy for detecting >50% stenoses in lower extremity arteries.^[113]^[114] Computed tomography angiography (CTA) serves as the gold standard for diagnosing acute mesenteric ischemia, offering high sensitivity and specificity in detecting vascular occlusions. In acute cases, CTA identifies occlusions with a sensitivity of approximately 93-96% and specificity up to 100%, enabling rapid assessment of arterial and venous involvement through multiplanar reconstructions and contrast enhancement.^[115]^[116]^[117] For cerebral ischemia, particularly in acute stroke, CTA excels at detecting large vessel occlusions (LVOs), which are critical for determining eligibility for thrombectomy, with diagnostic accuracy enhanced by multiphase protocols that improve visualization of collateral flow.^[118]^[119]^[120] Magnetic resonance imaging (MRI) with diffusion-weighted imaging (DWI) is highly sensitive for identifying acute cerebral ischemia, particularly the ischemic core and penumbra. DWI detects restricted diffusion of water molecules in affected tissue within minutes of onset, appearing as hyperintense areas on images, which correlates with cytotoxic edema in the infarct core.^[121]^[122] When combined with perfusion-weighted imaging (PWI), DWI reveals the penumbra as a mismatch region—areas of hypoperfusion without restricted diffusion—indicating potentially salvageable tissue for reperfusion therapy.^[123]^[124] Echocardiography provides real-time evaluation of cardiac ischemia by identifying regional wall motion abnormalities (RWMAs), which manifest as hypokinesis, akinesis, or dyskinesis in myocardial segments supplied by occluded coronary arteries. These changes occur within seconds of ischemia onset and can be quantified using standardized wall motion scoring systems, aiding in the localization of culprit vessels.^[125]^[126]^[127] Stress echocardiography further enhances detection by provoking ischemia-induced RWMAs during exercise or pharmacological stress.^[128] Recent advances in perfusion CT (CTP) and MRI have improved viability assessment in ischemic tissues across organs. CTP quantifies cerebral blood flow, volume, and transit time to delineate infarct core from penumbra, with automated software enhancing accuracy in stroke triage as of 2023-2025 studies. Emerging artificial intelligence (AI) tools for automated segmentation and mismatch analysis in CTP and MRI further streamline diagnosis and patient selection for therapy, as demonstrated in 2024-2025 research.^[129]^[130]^[131] Similarly, perfusion MRI, including dynamic contrast-enhanced techniques, evaluates myocardial viability by identifying hibernating myocardium with preserved perfusion reserve, supporting decisions for revascularization in chronic ischemia.^[132]^[133] These multimodal approaches integrate anatomical and functional data for precise prognosis and treatment planning.^[134]

Laboratory and Functional Tests

The ankle-brachial index (ABI) is a simple, non-invasive functional test for diagnosing peripheral artery disease, comparing systolic blood pressures in the ankles and arms; an ABI <0.9 indicates ischemia, with values <0.4 suggesting severe disease. It is recommended for screening in at-risk populations.^[113]^[135] Laboratory and functional tests play a crucial role in detecting ischemia, quantifying its severity, and stratifying patient risk across various organ systems. These tests include blood-based biomarkers that indicate cellular damage or metabolic derangements and dynamic assessments that provoke and reveal inducible ischemic changes. While imaging modalities provide anatomical localization, laboratory tests focus on biochemical signatures of injury, often correlating with perfusion deficits observed on scans. Cardiac troponin, a protein complex released from damaged cardiomyocytes, serves as the primary biomarker for myocardial ischemia. Levels begin to rise 3-6 hours after the onset of ischemia, peaking at 12-48 hours and remaining elevated for up to 10 days, enabling early diagnosis of acute coronary syndromes. In mesenteric ischemia, serum lactate elevation reflects anaerobic metabolism due to bowel hypoperfusion, with increased levels observed in the majority of acute cases, though it lacks specificity as a standalone diagnostic tool. Coagulation panels, particularly D-dimer assays, detect fibrin degradation products indicative of thrombotic processes underlying ischemic events, such as in acute coronary thrombosis or venous thromboembolism contributing to tissue hypoperfusion. High-sensitivity cardiac troponin (hs-cTn) assays represent a modern advancement, capable of detecting minute elevations from micro-injuries below the threshold of conventional tests, allowing for earlier identification of subtle myocardial damage and improved risk stratification in suspected ischemia. These assays measure troponin I or T with greater precision, revealing diurnal variations and low-level chronic elevations that signal ongoing ischemic risk. Functional tests assess ischemia under stress to uncover inducible deficits not evident at rest. Stress electrocardiography (ECG) evaluates for ST-segment changes during exercise or pharmacological provocation, identifying inducible myocardial ischemia with high sensitivity in patients able to exercise adequately. Stress echocardiography combines ultrasonic imaging with stress to visualize regional wall motion abnormalities, offering accurate detection of ischemia through transient contractile dysfunction, particularly useful when ECG findings are inconclusive. Positron emission tomography (PET) provides metabolic assessment by quantifying myocardial blood flow and glucose uptake with tracers like fluorine-18 fluorodeoxyglucose, distinguishing viable but ischemic tissue from infarcted areas and aiding prognosis in coronary artery disease.

Treatment

Acute Management

The acute management of ischemia prioritizes rapid restoration of perfusion to limit irreversible tissue damage, typically initiated after confirming the diagnosis through clinical evaluation and imaging. Reperfusion therapies form the cornerstone, aiming to dissolve or remove occlusive thrombi or emboli within critical time windows to salvage viable tissue. Supportive measures stabilize the patient and prevent secondary complications, while organ-specific interventions address the unique pathophysiology of affected regions such as the brain, heart, or intestines. Pharmacological reperfusion with thrombolytics is a first-line option in eligible patients. For acute ischemic stroke, intravenous alteplase (recombinant tissue plasminogen activator, tPA) is administered at a dose of 0.9 mg/kg (maximum 90 mg) within 4.5 hours of symptom onset, improving functional outcomes by approximately 30% compared to placebo when given early.^[136] This time window is based on evidence from randomized trials showing reduced disability at 3 months, though eligibility requires exclusion of hemorrhage via non-contrast CT.^[137] Recent 2025 data indicate alteplase may benefit select patients up to 24 hours with perfusion imaging mismatch, yielding better neurological recovery than standard care alone.^[138] Mechanical reperfusion via endovascular thrombectomy expands treatment eligibility, particularly for large vessel occlusions. In acute ischemic stroke, thrombectomy using stent retrievers or aspiration devices is recommended up to 6 hours universally and up to 24 hours in patients with favorable imaging profiles, such as small infarct core and penumbra mismatch, as demonstrated by the DAWN trial where it increased independent functional outcomes from 13% to 49%.^[139] 2025 updates refine selection for large-core infarcts, showing feasibility and safety in extended windows with simplified protocols, though overall time limits remain at 24 hours without further extension.^[140] Emerging alternatives include tenecteplase, a modified tPA with higher fibrin specificity; 2025 trials report improved recanalization rates (up to 65%) and excellent functional outcomes (modified Rankin Scale 0-1 in 45% of cases) when given at 0.25 mg/kg in the 4.5- to 24-hour window, without increased intracranial hemorrhage risk compared to alteplase.^[141] Supportive care accompanies reperfusion to optimize oxygenation, prevent thrombus propagation, and maintain hemodynamic stability. Supplemental oxygen is provided via nasal cannula to maintain saturation above 94% in hypoxemic patients, avoiding routine use in normoxic individuals to prevent vasoconstriction.^[142] Antiplatelet therapy with aspirin (initial 162-325 mg oral or rectal) is initiated within 24-48 hours post-reperfusion in stroke to reduce recurrent events by 12%, unless contraindicated by bleeding risk.^[136] Anticoagulation with unfractionated heparin is reserved for specific etiologies like atrial fibrillation or venous thrombosis, starting after imaging confirms no hemorrhage, as immediate use in arterial ischemia does not improve outcomes and raises bleeding risks.^[142] Organ-specific strategies tailor interventions to anatomy and acuity. In acute myocardial ischemia manifesting as ST-elevation myocardial infarction (STEMI), primary percutaneous coronary intervention (PCI) with stent placement is the gold standard, targeting door-to-balloon times under 90 minutes to achieve TIMI 3 flow in over 90% of cases and reduce 30-day mortality by 25-30%.^[143] Adjunctive dual antiplatelet therapy (aspirin plus P2Y12 inhibitor like ticagrelor) is loaded immediately, with anticoagulation using heparin during PCI.^[143] For acute mesenteric ischemia due to arterial embolism, catheter-directed or surgical embolectomy restores superior mesenteric artery flow, with technical success rates of 88% and in-hospital mortality around 26% when combined with intra-arterial thrombolysis in non-peritonitic cases.^[144] Systemic unfractionated heparin is initiated preoperatively at full dose (aPTT 40-60 seconds) to halt propagation, alongside fluid resuscitation and broad-spectrum antibiotics.^[144]

Preventive and Long-Term Strategies

Preventive strategies for ischemia focus on reducing the risk of recurrent events through targeted pharmacotherapy, lifestyle modifications, and, in select cases, surgical interventions. These approaches aim to address underlying risk factors such as atherosclerosis, hypertension, and thrombosis, thereby stabilizing plaques, improving vascular function, and enhancing overall cardiovascular health. Long-term adherence to these measures is crucial for sustained protection against ischemic episodes in organs like the heart, brain, and limbs. Pharmacotherapy plays a central role in secondary prevention following an ischemic event. Statins, such as atorvastatin, are widely prescribed to stabilize atherosclerotic plaques and lower low-density lipoprotein cholesterol levels, significantly reducing the incidence of recurrent coronary ischemia by up to 30% in high-risk patients. Angiotensin-converting enzyme (ACE) inhibitors, like ramipril, are recommended for managing hypertension, which is a key modifiable risk factor for ischemia; these agents decrease vascular resistance and prevent left ventricular remodeling, leading to a 20-25% reduction in cardiovascular events in patients with ischemic heart disease. Post-event, dual antiplatelet therapy with aspirin and clopidogrel is standard for at least 12 months in acute coronary syndrome survivors to inhibit platelet aggregation and prevent stent thrombosis or recurrent arterial occlusion, with evidence showing a 20% relative risk reduction in major ischemic outcomes compared to single-agent therapy. Lifestyle interventions are foundational for long-term ischemia prevention, offering benefits that complement pharmacotherapy. Smoking cessation is particularly impactful; quitting tobacco use can reduce the risk of recurrent myocardial infarction by 50% within one year by improving endothelial function and decreasing prothrombotic states. Adopting a heart-healthy diet, such as the Mediterranean pattern rich in fruits, vegetables, whole grains, and omega-3 fatty acids, alongside regular exercise (at least 150 minutes of moderate aerobic activity per week), helps control obesity and dyslipidemia, lowering ischemic event rates by 30-50% in adherent individuals with prior cardiovascular disease. For patients with chronic ischemia in specific vascular beds, surgical options provide durable revascularization. Peripheral artery bypass grafting, often using autologous vein or synthetic grafts, is indicated for chronic limb-threatening ischemia to restore blood flow distal to occlusions, achieving limb salvage rates of 70-80% at five years and preventing recurrent ischemic ulcers or gangrene. Carotid endarterectomy is a proven procedure for symptomatic high-grade carotid artery stenosis (70-99%), reducing the risk of ipsilateral stroke by 65% over two years compared to medical therapy alone in appropriately selected patients. Emerging therapies, including stem cell-based approaches, hold promise for chronic cardiac ischemia, particularly in patients with refractory angina or heart failure post-ischemia. Preclinical and early-phase clinical trials as of 2025 demonstrate that mesenchymal stem cell infusions can promote angiogenesis and reduce infarct size, with some studies reporting modest improvements in left ventricular ejection fraction (2-5%) and symptom relief; however, larger randomized trials are needed to confirm long-term efficacy and safety.

Prognosis and Complications

Outcomes by Organ

Ischemia outcomes vary significantly depending on the affected organ, with survival and recovery rates influenced by the rapidity of intervention and the extent of tissue damage. In the heart, acute myocardial infarction treated with timely percutaneous coronary intervention (PCI) within recommended door-to-balloon times yields high short-term survival, with in-hospital mortality rates around 5% in large cohorts.^[145] However, despite successful reperfusion, approximately 20% of patients develop heart failure within the first year post-event, often due to residual ventricular dysfunction.^[146] Cerebral ischemia, as in acute ischemic stroke amenable to endovascular thrombectomy, shows moderate recovery potential, with about 46% of patients achieving good functional outcomes (modified Rankin Scale 0-2) at 90 days in pooled analyses of major trials.^[147] This figure reflects improvements from earlier benchmarks, though outcomes remain poorer in cases with large vessel occlusions or delayed treatment.^[148] Mesenteric ischemia carries a grave prognosis, with untreated cases exhibiting mortality rates near 100%, primarily from bowel necrosis and systemic complications.^[149] Intervention, whether surgical or endovascular, reduces this to around 30-50%, underscoring the critical need for early diagnosis.^[144] In the limbs, acute ischemia often results from arterial embolism or thrombosis, with amputation risks ranging from 10-20% within 30 days even after revascularization attempts.^[150]^[151] Factors such as comorbid atherosclerosis exacerbate these rates, leading to substantial functional impairment in survivors.^[151] Renal ischemia, typically from embolism, thrombosis, or hypoperfusion, is associated with acute kidney injury and carries an in-hospital mortality of 20-50% in severe cases, with survivors at risk for chronic kidney disease and end-stage renal disease.^[152] Cutaneous ischemia, often linked to systemic vasculitis or embolism, is rare but increases relapse risk and overall mortality, with amputation rates higher in tobacco users (up to 20-30% in affected limbs).^[153]

Long-Term Effects

Long-term effects of ischemia encompass a range of chronic complications that significantly impair quality of life and overall health. In neurological contexts, such as post-ischemic stroke, cognitive decline is a prevalent issue, affecting 30-70% of survivors and often involving deficits in executive function, memory, and attention that persist for years.^[154] Post-stroke depression occurs in approximately 30% of cases, contributing to reduced functional independence and increased risk of recurrent events.^[155] Cardiac ischemia, particularly following myocardial infarction, frequently leads to chronic heart failure, which develops in a substantial proportion of patients due to ongoing myocardial remodeling and systolic dysfunction.^[156] Arrhythmias, including ventricular tachycardia and atrial fibrillation, are common long-term sequelae, occurring in up to 20-30% of survivors and heightening the risk of sudden cardiac death.^[157] In myocardial infarction survivors, life expectancy is reduced by approximately 2 years on average for middle-aged patients as of registry data through 2022, though up to 9-10 years in cases with reduced left ventricular function, influenced by factors such as age, comorbidities, and treatment efficacy.^[158] Systemically, severe ischemia can precipitate multi-organ failure through mechanisms like widespread hypoperfusion and inflammatory cascades, as seen in critical cases involving both cardiac and cerebral events.^[159] Rehabilitation efforts, including physical therapy, play a crucial role in mitigating these effects, with early interventions improving functional outcomes and reducing disability in 50-70% of post-ischemic stroke patients.^[160] Projections indicate that disability-adjusted life years (DALYs) attributable to ischemic heart disease and stroke will increase by over 50% globally by 2050, underscoring the growing burden and need for enhanced rehabilitative strategies.^[161]

History and Terminology

Historical Development

The concept of ischemia, characterized by inadequate blood supply leading to tissue damage, emerged through early pathological observations in the 17th century. In 1658, Swiss physician Johann Jakob Wepfer conducted autopsies on stroke victims and identified arterial obstructions by clots in approximately half of cases, distinguishing hemorrhagic apoplexy from non-hemorrhagic forms.^[162] These findings shifted focus from ventricular theories to vascular causes, laying groundwork for understanding ischemia in organs like the brain.^[162] Advancements in the 20th century revolutionized ischemia detection. Dutch physiologist Willem Einthoven invented the string galvanometer electrocardiograph (ECG) in 1903, enabling noninvasive recording of cardiac electrical activity and identification of ischemic changes such as ST-segment deviations in acute myocardial events.^[163] In 1929, German surgeon Werner Forssmann performed the first human cardiac catheterization on himself, injecting contrast to visualize the right heart, which paved the way for angiographic techniques to diagnose coronary and cerebral vessel occlusions underlying ischemia.^[164] Key therapeutic milestones followed in the late 20th century. The 1980s saw the rise of thrombolysis through large-scale trials, notably the GISSI-1 study in 1986, which randomized over 11,000 patients with acute myocardial infarction and demonstrated an 18% relative reduction in in-hospital mortality with intravenous streptokinase administered within 12 hours (with greater benefit for earlier treatment, up to 47% reduction within 1 hour of symptom onset).^[165] The endovascular thrombectomy era began around 2015 with the MR CLEAN trial, a multicenter randomized study showing that intra-arterial mechanical clot removal in acute ischemic stroke due to large-vessel occlusion improved functional outcomes in 32.6% of patients compared to 19.1% with standard care alone.^[166] By 2025, artificial intelligence has integrated with historical imaging modalities to enhance ischemia diagnosis. AI models now automate analysis of CT and MRI scans, achieving high accuracy (AUC around 0.80) in detecting large-vessel occlusions and segmenting ischemic lesions from multimodal data, including diffusion-weighted imaging, thereby accelerating workflows and improving outcomes in acute settings.^[167]

Etymology and Pronunciation

The term "ischemia" derives from the Greek words ἴσχω (iskhō), meaning "to keep back" or "restrain," and αἷμα (haima), meaning "blood," collectively denoting the restriction or stoppage of blood flow.^[168] This etymological root reflects the condition's core feature of diminished blood supply to tissues. The term was coined in 1858 by German pathologist Rudolf Virchow to characterize reduced perfusion in organs or tissues, marking its introduction into medical nomenclature as a precise descriptor of circulatory insufficiency.^[5] In English, "ischemia" is pronounced /ɪˈskiːmiə/, with emphasis on the second syllable.^[168] The adjective form is "ischemic," used to describe conditions or processes involving such blood flow restriction, such as ischemic heart disease. A related pathophysiological concept is ischemia-reperfusion injury, which refers to additional tissue damage that occurs upon restoration of blood flow to an ischemic area, often due to oxidative stress and inflammation.^[169] During the 20th century, the term "ischemia" evolved from a primarily descriptive label for observed reductions in blood flow—often noted in autopsies—to a central pathophysiological entity underpinning acute events like myocardial infarction and stroke, with experimental and clinical studies elucidating its cellular and molecular mechanisms.^[170] This shift was driven by advancements in understanding coronary occlusion and tissue responses, transforming ischemia into a foundational concept in cardiovascular and cerebrovascular pathology.

References

[1]
Ischemia: Types, Causes & Symptoms - Cleveland Clinic
Ischemia is a less-than-normal amount of blood flow to part of your body. This lack of blood flow means your tissues aren't getting the oxygen they need.Missing: credible | Show results with:credible
[2]
Ischemic Heart Disease and Silent Ischemia
Dec 11, 2024 · Ischemia when blood flow and oxygen is reduced in a part of the body. Cardiac ischemia is decreased blood flow and oxygen to the heart ...
[3]
Ischemic Heart Disease - Cardiovascular Disability - NCBI Bookshelf
Ischemia is defined as inadequate blood supply (circulation) to a ... Treatment of ischemia may involve surgical or cardiac interventional approaches.Diagnostic Criteria And... · Exercise Stress Tests · Disability
[4]
Myocardial ischemia: lack of coronary blood flow, myocardial ... - NIH
Myocardial ischemia is defined as an imbalance between supply (of oxygen or of coronary blood flow) and demand (largely for contractile function).
[5]
Physiology, Oxygen Transport - StatPearls - NCBI Bookshelf - NIH
In tissues, oxygen diffuses down its concentration gradient from high to low concentrations and is delivered to cells.
[6]
The Circulatory System and Oxygen Transport - NCBI - NIH
Hence, increasing blood flow will increase the delivery of oxygen via the blood to the tissues. The block labeled “Metabolite Washout” plays a key role in ...
[7]
Physiology of Oxygen Transport and its Determinants in Intensive ...
In this article, we discuss the physiology of oxygen transport from the alveoli to the tissue, the alveolar gas equation and the oxyhemoglobin dissociation ...
[8]
Myocardial ischemia reperfusion injury - from basic science to ...
Primarily, no blood flow to the heart causes an imbalance between oxygen demand and supply, named ischemia (from the greek isch-, restriction and -haema, blood) ...<|separator|>
[9]
Myocardial Infarction - StatPearls - NCBI Bookshelf - NIH
Aug 8, 2023 · Myocardial infarction (MI), colloquially known as heart attack, is caused by decreased or complete cessation of blood flow to a portion of the myocardium.
[10]
Pathobiology of Myocardial Ischemia and Reperfusion Injury
Acute Myocardial Ischemic Injury and Infarction The period of reversible injury lasts for 15 minutes and then is followed by the transition from reversible to ...Modes Of Cell Injury And... · Acute Myocardial Ischemic... · Ischemic Heart Disease
[11]
Myocardial ischemia/reperfusion: Pathophysiology of heart disease
Jan 12, 2024 · The alterations in blood flow, contractile function, and electrical function remain reversible for 20–40 min after complete coronary occlusion, ...
[12]
Cerebral Ischemia: Variability & Reversibility in Monkeys
Deficits from ischemia were commonly reversible ... Variability and reversibility of focal ischemia were probably related to variable collateral circulation.
[13]
Acute Mesenteric Ischemia - StatPearls - NCBI Bookshelf - NIH
Acute mesenteric ischemia is caused by a sudden decline in blood flow through the mesenteric vessels. Diagnosis can be difficult because symptoms are typically ...
[14]
Global burden, trends, and inequalities of ischemic heart disease ...
Nov 23, 2023 · In 2019, there were a total of 197 million cases of IHD globally, with 9.14 million deaths, and young adults aged 25–49 accounted for 9.15% of ...Abstract · Methods · Results · Discussion
[15]
Global burden of cardiovascular diseases: projections from 2025 to ...
Aug 25, 2025 · Cardiovascular disease (CVD) is the leading cause of death worldwide, with an expected 90% increase in prevalence and a 73.4% increase in the ...
[16]
Global, Regional, and National Burden of Cardiovascular Diseases ...
Sep 24, 2025 · Ischemic stroke was the third-largest cause of DALYs among CVDs globally in 2023. The age-standardized DALY rate of ischemic stroke has been ...
[17]
Global, regional, and national trends in ischaemic stroke burden and ...
Apr 24, 2025 · The total number of IS cases still increased significantly from 33.2 million to 68.4 million. ... patients with acute ischemic stroke. JAMA. (2020) ...
[18]
Cardiovascular diseases (CVDs) - World Health Organization (WHO)
Jul 31, 2025 · An estimated 19.8 million people died from CVDs in 2022, representing approximately 32% of all global deaths. Of these deaths, 85% were due to ...
[19]
Global, regional, and national burden of ischemic stroke, 1990–2021
Jul 27, 2024 · The global DALYs for ischemic stroke in 2021 were 70,357,911.9 (95% UI: 64,329,575.6–76,007,063), with an age-standardized DALY rate of ...
[20]
Cardiovascular disease burden due to productivity losses in ... - NIH
In 2018, there were 4.4 million deaths due to CVD across the 54 countries, with 7.1 million working years lost. This represented productivity losses due to ...
[21]
The economic burden of ischaemic heart diseases on health systems
Feb 12, 2025 · IHDs impose a substantial economic burden on health systems globally. Economic costs in countries exceed per capita public health expenditure, primarily driven ...
[22]
Risk Factors for Stroke - CDC
May 15, 2024 · Age. The older you are, the more likely you are to have a stroke. The chance of having a stroke about doubles every 10 years after age 55.
[23]
Risk Factors for Coronary Artery Disease - StatPearls - NCBI Bookshelf
Non-modifiable risk factors include age, gender, ethnicity, and family history of CAD. Modifiable risk factors include hypertension, hyperlipidemia ...Missing: air | Show results with:air
[24]
Stroke Risk Factors, Genetics, and Prevention - PMC
Non-modifiable risk factors (also called risk markers) for stroke include age, sex, race-ethnicity and genetics. In general, stroke is a disease of aging. The ...
[25]
META-ANALYSIS OF FACTOR V LEIDEN AND ISCHEMIC STROKE ...
Factor V Leiden is the most common prothrombotic genetic predisposition. It is present in 5.2% of Caucasian Americans and 1.2% of African Americans, though it ...
[26]
Stroke Risk Factors, Genetics, and Prevention | Circulation Research
Feb 3, 2017 · In general, stroke is a disease of aging. The incidence of stroke increases with age, with the incidence doubling for each decade after 55 years ...Modifiable Risk Factors · Inflammation And Infection · Targeted Lifestyle...
[27]
Air Pollution and Stroke: An Emerging Challenge From Cardio ...
Jun 27, 2025 · Although they are both established risk factors for stroke, ambient PM pollution ranks first among environmental risks for stroke, accounting ...
[28]
The Lancet Neurology: Air pollution, high temperatures, and ...
Sep 18, 2024 · Metabolic risk factors—especially high BMI, high systolic blood pressure, and high LDL cholesterol—contributed to the most stroke burden across ...
[29]
Hypertension and diabetes including their earlier stage are ... - NIH
Jul 19, 2022 · However, the risk was greatest in people with both hypertension and DM, suggesting a synergistic effect with both diseases. BP blood pressure, ...
[30]
Unstable Angina - StatPearls - NCBI Bookshelf - NIH
Jun 22, 2025 · Unstable angina typically presents as chest pain that is new in onset, occurs at rest, or exhibits a worsening pattern. The condition is ...
[31]
Acute coronary syndrome - Symptoms and causes - Mayo Clinic
Apr 26, 2025 · Acute coronary syndrome is a term that describes a range of conditions related to sudden, reduced blood flow to the heart.Overview · Symptoms · Causes
[32]
Angina (Chest Pain) - Symptoms - NHLBI - NIH
Jul 10, 2023 · Aside from pain in the upper body, symptoms of angina may include: Shortness of breath. Extreme tiredness.
[33]
Acute Myocardial Infarction - StatPearls - NCBI Bookshelf - NIH
Sep 3, 2023 · Cardiac findings: The heart may exhibit lateral displacement of the apical impulse, a soft S1 sound, a palpable S4 sound, and a new mitral ...Missing: pallor | Show results with:pallor
[34]
A Qualitative Study of Symptom Experiences of Women with Acute ...
Furthermore, many women have ACS symptoms that are intermittent, often evolving over hours, days, or weeks. One possible explanation for symptom differences is ...
[35]
Detection of silent myocardial ischemia in asymptomatic diabetic ...
Silent myocardial ischemia occurs in greater than one in five asymptomatic patients with type 2 diabetes. Traditional and emerging cardiac risk factors were ...
[36]
A silent myocardial infarction in the diabetes outpatient clinic - NIH
Oct 28, 2013 · Silent myocardial ischaemia (SMI) is an important clinical entity. · SMI is common and occurs with increased frequency in patients with diabetes.
[37]
Stroke - Symptoms and causes - Mayo Clinic
Dec 13, 2024 · This causes reduced blood flow, known as ischemia. Blocked or narrowed blood vessels can be caused by fatty deposits that build up in blood ...
[38]
Stroke - Symptoms - NHLBI - NIH
May 26, 2023 · Sudden confusion, trouble speaking, or trouble understanding speech; Sudden numbness or weakness, especially on one side of the body; Sudden ...
[39]
Signs and Symptoms of Stroke - CDC
Oct 24, 2024 · Sudden trouble walking, dizziness, loss of balance, or lack of coordination. Sudden severe headache with no known cause. Call 9-1-1 right ...
[40]
Transient ischemic attack (TIA) - Symptoms and causes - Mayo Clinic
Feb 9, 2024 · A transient ischemic attack (TIA) is a short period of symptoms similar to those of a stroke. It's caused by a brief blockage of blood flow to the brain.
[41]
Stroke Symptoms and Warning Signs
... symptoms that occur in the blood circulation to the front part of the brain (called anterior circulation strokes). Symptoms include: Vertigo, sensation like ...Women and Stroke · Stroke survivor dances at... · The F.A.S.T. Experience
[42]
Posterior Circulation Ischemic Stroke - PMC - PubMed Central
The most common clinical signs are unilateral limb weakness (38%), gait ataxia (31%), unilateral limb ataxia (30%), dysarthria (28%), nystagmus (24%), and ...
[43]
Silent brain infarcts and the risk of dementia and cognitive decline
Elderly people with silent brain infarcts have an increased risk of dementia and a steeper decline in cognitive function than those without such lesions.Missing: ischemia | Show results with:ischemia
[44]
Memory after silent stroke: Hippocampus and infarcts both matter - NIH
Subclinical brain infarcts are present in about one-third of older adults, and are associated with a 2-fold risk of dementia and a steeper decline in age- ...
[45]
Mesenteric Artery Ischemia - StatPearls - NCBI Bookshelf - NIH
Mesenteric ischemia refers to ischemia that affects the blood vessels of the small intestine. It can be secondary to occlusive or nonocclusive obstruction of ...Continuing Education Activity · History and Physical · Treatment / ManagementMissing: definition | Show results with:definition
[46]
Mesenteric Ischemia: Causes, Symptoms & Treatment
Mesenteric ischemia is an uncommon and serious medical condition that happens when parts of your digestive system don't get enough blood flow and oxygen.Missing: thrombotic | Show results with:thrombotic
[47]
Acute Mesenteric Ischemia - Medscape Reference
Feb 1, 2024 · AMI as arterial disease may be subdivided into nonocclusive mesenteric ischemia (NOMI) and occlusive mesenteric arterial ischemia (OMAI); OMAI ...
[48]
Peripheral artery disease (PAD) - Symptoms and causes - Mayo Clinic
Aug 9, 2024 · Symptoms · Leg pain when walking. · Muscle pain or cramping in the arms or legs, often in the calf. · Muscle pain in the arms or legs that begins ...
[49]
Criticial Limb Ischemia: Epidemiology - PMC - NIH
The clinical presentation of critical limb ischemia may vary from no symptoms to intermittent claudication, atypical leg pain, rest pain, ischemic ulcers, or ...
[50]
Acute Lower Limb Ischemia—Etiology, Pathology, and Management
Etiologies for nontraumatic ALI can be broadly classified into embolic and thrombotic events. ... The most common etiology is acute thrombosis of a previous ...
[51]
Management of Critical Limb Ischemia - PMC - NIH
Critical limb ischemia is a clinical syndrome of ischemic pain at rest and/or ischemic tissue loss such as non-healing ulcers or gangrene, related to peripheral ...
[52]
Acute Limb Ischemia - PMC - NIH
The symptoms of ALI are abrupt with pain, numbness, and coldness of lower limb, and paresthesia, contracture, and irreversible purpura will appear with the ...
[53]
Acute limb ischaemia - PMC - NIH
Clinical features. Apart from paralysis (inability to wiggle toes or fingers) and anaesthesia (loss of light touch over the dorsum of the foot or hand), the ...
[54]
Pressure Ulcer Management: Staging and Prevention
Pressure ulcers result from ischemia due to pressure closing the microarterioles, particularly at pressure points such as the heels, sacrum, and elbows.
[55]
Livedo reticularis - DermNet
Livedo reticularis results from a disturbance of blood flow to the skin, causing low blood flow and reduced oxygen tension to the skin. Cutaneous vasculature is ...
[56]
Ischemic ulcers - self-care: MedlinePlus Medical Encyclopedia
Jun 11, 2024 · Ischemic means reduced blood flow to an area of the body. Poor blood flow causes cells to die and damages tissue. Most ischemic ulcers occur on ...
[57]
Raynaud Disease - StatPearls - NCBI Bookshelf - NIH
Severe Raynaud phenomenon may result in tissue ischemia, leading to necrosis followed by amputation of the affected area.
[58]
Digital Ischemia in Scleroderma Spectrum of Diseases - PMC - NIH
Digital ischemia (digital ulcers (DUs)) is the hallmark of SSc-related vasculopathy and is characterized by endothelial dysfunction leading to intimal ...
[59]
Ischemic Limb Complications in the ICU - Endovascular Today
Grade I acute ischemia, with coolness, mottling, or other manifestations of ischemia ... cutaneous necrosis if the skin perfusion is compromised. Further, limbs ...
[60]
Pressure Ulcer - StatPearls - NCBI Bookshelf
Jan 3, 2024 · Pressure injuries are localized skin and soft tissue injuries that develop due to prolonged pressure exerted over specific areas of the body, typically bony ...
[61]
Acute Kidney Injury - StatPearls - NCBI Bookshelf - NIH
Nov 25, 2023 · Acute kidney injury (AKI), previously known as acute renal failure, denotes a sudden and often reversible reduction in kidney function.Missing: flank pain hematuria
[62]
Renal Artery Stenosis - StatPearls - NCBI Bookshelf
Renal artery stenosis is narrowing of the one or both of renal arteries. It is the major cause of hypertension.
[63]
Renal infarction - PMC - NIH
Sep 3, 2012 · Renal infarction is an underdiagnosed and under-reported phenomenon, and needs to be diagnosed rapidly to prevent permanent loss of renal function.Missing: injury | Show results with:injury
[64]
Cardiorenal Syndrome - StatPearls - NCBI Bookshelf - NIH
Jun 22, 2025 · Patients may also demonstrate manifestations of decreased cardiac output with hypotension, fatigue, diminished peripheral pulses, and abnormal ...
[65]
Splenic Infarcts - StatPearls - NCBI Bookshelf - NIH
Typical presentation includes left-sided abdominal pain in a person with an underlying hematologic disorder, hypercoagulable state, blood-borne malignancy, ...
[66]
Assessment of Clinical Conditions Associated With Splenic ... - NIH
Jul 13, 2020 · The classic splenic infarction presents with acute pain and tenderness in the left upper quadrant or flank area.
[67]
Ischemic acute pancreatitis with pancreatic pseudocyst in a patient ...
Mar 21, 2015 · Ischemic pancreatitis is a rare condition but should be considered in a patient with upper abdominal pain and elevated amylase in the context of an abdominal ...
[68]
Acute Pancreatitis - StatPearls - NCBI Bookshelf - NIH
Aug 2, 2025 · Clinically, patients present with sudden epigastric pain, often radiating to the back, accompanied by nausea, vomiting, and elevated serum ...
[69]
Amaurosis Fugax - StatPearls - NCBI Bookshelf
Retinal artery occlusion (central or branch): Presents as sudden, painless monocular vision loss, distinguished by retinal whitening and a cherry-red spot on ...Introduction · Histopathology · Evaluation · Differential Diagnosis
[70]
Central Retinal Artery Occlusion - StatPearls - NCBI Bookshelf - NIH
May 2, 2024 · Visual acuity typically means no perception of light, and the cherry red spot at the macula may not be visible due to choroidal ischemia.
[71]
Ocular Ischemic Syndrome - StatPearls - NCBI Bookshelf
In its acute state, OIS manifests as amaurosis fugax and retinal artery ... cherry-red spot in the retina (12%).[10] The presentation visual acuity ...
[72]
Testicular Torsion - StatPearls - NCBI Bookshelf - NIH
Testicular torsion often presents as an abrupt onset of unilateral scrotal pain. The pain may be constant or intermittent but not positional. The patient may ...
[73]
Ovarian Torsion - StatPearls - NCBI Bookshelf - NIH
The patient most commonly will present with lower abdominal pain or pelvic pain. Pain can be sharp, dull, constant, or intermittent. Pain may radiate to the ...
[74]
Paradoxical Embolism - StatPearls - NCBI Bookshelf - NIH
Sep 4, 2023 · Paradoxical embolism (PDE) occurs when a thrombus crosses an intracardiac defect into the systemic circulation.Missing: via | Show results with:via
[75]
Coronary Plaque Disruption | Circulation
Coronary atherosclerosis is by far the most frequent cause of ischemic heart disease, and plaque disruption with superimposed thrombosis is the main cause ...
[76]
Atherosclerosis and Insulin Resistance: Is There a Link Between ...
May 23, 2025 · A significant portion of these cases (80%) is linked to atherosclerosis, which can lead to severe conditions like ischemic heart disease and ...
[77]
Mechanisms of Plaque Rupture - NCBI - NIH
The early development of the plaque is dependent upon interactions between damaged endothelial cells, vessel wall smooth muscle cells and circulating ...
[78]
Mechanisms of Plaque Formation and Rupture | Circulation Research
Jun 6, 2014 · Sites with low or oscillatory endothelial shear stress, located near branch points and along inner curvatures, are most susceptible, and ...
[79]
One of the most urgent vascular circumstances: Acute limb ischemia
Symptoms and signs include severe pain, hypesthesia, and weakness of the affected limb; myoglobinuria and elevation of the creatine kinase level often occur.
[80]
Acute Limb Ischemia Secondary to Patent Foramen Ovale ... - PubMed
Acute limb ischemia is a rare manifestation of PFO-mediated paradoxical embolism that requires a high index of suspicion for diagnosis.Missing: via | Show results with:via
[81]
Prinzmetal Angina - StatPearls - NCBI Bookshelf
Vasospastic angina, variant angina, or Prinzmetal angina is a known clinical entity characterized by chest pain at rest with transient ischemic ...
[82]
Coronary Vasospastic Angina: A Review of the Pathogenesis ...
Coronary vasospastic angina (VSA) is characterised by transient and reversible vasoconstriction of the coronary vasculature leading to myocardial ischemia. It ...
[83]
Vascular Extremity Trauma - StatPearls - NCBI Bookshelf
Vascular trauma can come in three forms: blunt, penetrating, or combination. These injuries can occur in a civilian or military setting.Epidemiology · History and Physical · Treatment / Management · Complications
[84]
Acute Compartment Syndrome - StatPearls - NCBI Bookshelf - NIH
Acute compartment syndrome occurs when there is increased pressure within a closed osteofascial compartment, resulting in impaired local circulation.
[85]
Iatrogenic Vascular Injuries in Elective Abdominal and Pelvic ... - NIH
Vascular injuries rarely occur in elective abdominal and pelvic surgeries. However, when they happen, they are fatal.
[86]
Iatrogenic Percutaneous Vascular Injuries: Clinical Presentation ...
Restenosis is the most common complication following endovascular peripheral arterial interventions, particularly for long segments, occurring at a rate of up ...
[87]
Hypovolemia and Hypovolemic Shock - StatPearls - NCBI Bookshelf
Jun 1, 2025 · Hypovolemic shock is a life-threatening condition caused by a significant reduction in blood volume, which prevents the heart from pumping enough blood to meet ...
[88]
Clinical review: Hemorrhagic shock - PMC - PubMed Central
This review addresses the pathophysiology and treatment of hypovolemic shock produced by hemorrhage, which is also known as hemorrhagic shock. Physiologic ...
[89]
Vascular Reperfusion Injury - StatPearls - NCBI Bookshelf - NIH
Aug 14, 2023 · Vascular reperfusion injury is a common complication encountered in clinical settings; post-myocardial infarction, cerebral ischemic stroke, limb injuries as ...Vascular Reperfusion Injury · Pathophysiology · Treatment / Management
[90]
Cardiogenic Shock - StatPearls - NCBI Bookshelf
Diminished heart sounds, S3 or S4, may be present, murmurs in the presence of valvular disorders such as mitral regurgitation or aortic stenosis. Pulmonary ...Missing: pallor | Show results with:pallor
[91]
CT hypoperfusion complex | Radiology Reference Article
Sep 18, 2024 · CT hypoperfusion complex is most commonly described in the context of post-traumatic hypovolemic shock but can also occur in 1,2: sepsis. severe ...
[92]
Takayasu Arteritis - StatPearls - NCBI Bookshelf
Takayasu arteritis, aka pulseless disease, is a systemic inflammatory condition which leads to damage of the medium and large arteries and their branches.Introduction · Pathophysiology · History and Physical · Treatment / Management
[93]
Cerebrovascular Ischemic Events in Patients With Takayasu Arteritis
Mar 31, 2022 · Takayasu arteritis (TA) is a large vessel vasculitis that may complicate with cerebrovascular ischemic events.
[94]
Antiphospholipid Syndrome - StatPearls - NCBI Bookshelf - NIH
May 6, 2024 · Antiphospholipid syndrome is characterized by the presence of antiphospholipid antibodies in the setting of thrombosis or pregnancy loss or complications.
[95]
Hypercoagulable State in Patients With Antiphospholipid Syndrome ...
Hypercoagulable State in Patients With Antiphospholipid Syndrome Is Related to High Induced Tissue Factor Expression on Monocytes and to Low Free Protein S.
[96]
Report of cold agglutinins in a patient with acute ischemic stroke
Oct 30, 2015 · We present a case of an elderly man with acute cerebral infarction probably due to cold agglutinin disease.
[97]
Ergotamine-Induced Upper Extremity Ischemia: A Case Report - PMC
Ergotamine-induced vascular ischemia is rare, but potentially serious complication may be induced through two mechanisms: vasospasm and thrombus formation.
[98]
Ergotism: Case Report and Review of the Literature - PMC - NIH
Feb 9, 2015 · The direct vasoconstrictive effect that is associated with ergotism curiously targets medium-sized vessels, notably the external iliac artery ...<|separator|>
[99]
Mechanisms Underlying Acute Protection from Cardiac Ischemia ...
During ischemia, when ATP is progressively deleted, ion pumps cannot function resulting in a rise in calcium (Ca2+), which further accelerates ATP depletion.
[100]
Lactate: the ugly duckling of energy metabolism - PMC - NIH
Jul 20, 2020 · Lactate production increases when the demand for ATP and oxygen exceeds supply, as occurs during intense exercise and ischaemia.Missing: deprivation | Show results with:deprivation
[101]
Calcium in Ischemic Cell Death - American Heart Association Journals
A calcium-related mechanism was proposed more than two decades ago to explain cell necrosis incurred in cardiac ischemia and muscular dystrophy.
[102]
Role of Oxidative Stress in Reperfusion following Myocardial ...
May 18, 2021 · This article reviews the pathological mechanisms of oxidative stress involved in reperfusion injury and the interventions for different pathways ...
[103]
Myocardial Stunning and Hibernation - StatPearls - NCBI - NIH
Feb 15, 2025 · A "stunned" myocardium refers to myocardial tissue experiencing transient, reversible contractile dysfunction due to acute ischemia.
[104]
Myocardial Hibernation | Circulation
Hibernation defines one form of pathophysiological response to myocardial ischemia, the other two being stunning and ischemic preconditioning. Myocardial ...
[105]
Ischemia/Reperfusion - PMC - PubMed Central
Although the critical time periods of ischemia that the brain, heart, and kidneys can withstand before irreversible cell injury occurs are clearly demarcated, ...
[106]
None
### Timelines for Ischemia in Brain and Heart
[107]
Neuroanatomy, Circle of Willis - StatPearls - NCBI Bookshelf
The circle of Willis acts to provide collateral blood flow between the anterior and posterior circulations of the brain, protecting against ischemia in the ...
[108]
Acute Stroke Diagnosis - PMC - PubMed Central - NIH
Jul 1, 2009 · History and physical examination remain the pillars of diagnosing stroke. The most common historical feature of an ischemic stroke is its acute ...
[109]
Myocardial ischemia - Diagnosis & treatment - Mayo Clinic
Myocardial ischemia reduces blood flow to the heart and may cause chest pain – but not always. Learn all the signs and symptoms and how to treat it.
[110]
Ischemic Stroke - StatPearls - NCBI Bookshelf - NIH
Feb 21, 2025 · Ischemic stroke, the most common type of stroke, is caused by thrombotic or embolic occlusion that reduces blood flow to the brain. The ...
[111]
Clinical diagnosis and prognosis of acute limb ischemia - PubMed
Proper diagnosis involves history, physical examination, and techniques such as Doppler assessment, contrast-enhanced magnetic resonance angiography, or ...
[112]
Pulmonary embolism: the diagnosis, risk-stratification, treatment and ...
The Wells score (Table 1) consists of 6 objective questions and one subjective question asking whether “PE is the most likely diagnosis.” Based on the score ( ...
[113]
A case of ascending aortic dissection mimicking acute myocardial ...
The symptoms of aortic dissection may be variable and can mimic other more common conditions such as myocardial ischemia. We report a case of a 60-year-old ...
[114]
Diagnostic Role of Multi-Detector Computed Tomography in Acute ...
MDCTA is the best imaging modality in the diagnosis of acute mesenteric ischemia, with a sensitivity of 94% and a specificity of 95% [9,21,27,28]. The optimal ...
[115]
Mesenteric Ischemia: A Comprehensive Review of the Role of ...
Aug 18, 2025 · The gold standard for diagnosis is computed tomography angiography (CTA) with a substantially high sensitivity and specificity [4, 6]. CTA ...
[116]
Mesenteric Ischemia | SAEM
Recent studies have shown CTA to have a sensitivity of 93% and specificity up to 100% for mesenteric ischemia.Missing: detection | Show results with:detection<|separator|>
[117]
Diagnostic accuracy of automated occlusion detection in CT ... - NIH
The main purpose of CT angiography is the detection of large vessel occlusions (LVOs) as this determines whether a patient is eligible for mechanical ...
[118]
Fast Automatic Detection of Large Vessel Occlusions on CT ...
Nov 4, 2019 · Intracranial anterior circulation LVOs and proximal M2 occlusions can be rapidly and reliably detected by an automated detection tool.
[119]
Multiphase CT angiography increases detection of anterior ...
Multiphase CTA is an innovative, user-friendly imaging tool that can improve diagnostic accuracy for anterior circulation intracranial occlusions, even when ...
[120]
Diffusion-weighted imaging in acute ischemic stroke
Mar 25, 2025 · Diffusion-weighted imaging (DWI) is a commonly performed MRI sequence for the evaluation of acute ischemic stroke and is very sensitive in the detection of ...
[121]
Diffusion- and Perfusion-Weighted MRI | Stroke
With DWI it is possible to identify severely ischemic brain regions within minutes to hours after stroke onset. A decrease in the apparent diffusion coefficient ...
[122]
Refined ischemic penumbra imaging with tissue pH and diffusion ...
Diffusion and Perfusion MRI. Diffusion-weighted imaging (DWI) is currently the operational gold standard for defining the ischemic core [8, 40]. It has been ...
[123]
Penumbra detection using PWI/DWI mismatch MRI in a rat stroke ...
Jun 6, 2012 · Perfusion-diffusion (perfusion-weighted imaging (PWI)/diffusion-weighted imaging (DWI)) mismatch is used to identify penumbra in acute stroke.
[124]
Echocardiographic assessment of myocardial ischemia - PMC - NIH
Jul 6, 2016 · In patients with thoracic pain, we are able to localize regional wall motion abnormalities using wall motion scores (28) (Figure 1) at rest and ...
[125]
Role of echocardiography in acute myocardial infarction - UpToDate
Severe ischemia produces regional wall motion abnormalities (RWMAs) that can be visualized echocardiographically within seconds of coronary artery occlusion ...Missing: cardiac | Show results with:cardiac
[126]
Pattern and Prognostic Impact of Regional Wall Motion ...
Nov 10, 2023 · Regional wall motion abnormalities (WMAs) after myocardial infarction are associated with adverse remodeling and increased mortality in the short to medium ...
[127]
Assessment of regional wall motion abnormalities with real-time 3 ...
The purpose of this study was to assess the feasibility of using real-time 3-dimensional (RT3D) echocardiography to detect regional wall motion abnormalities.
[128]
The Role of CT Perfusion in the Evaluation and Management ... - MDPI
This review aimed to assess the role of CTP in patient selection for reperfusion therapy, its prognostic value, and the influence of technical factors ...
[129]
https://www.mdpi.com/2075-1729/15/11/1693
[130]
The Role of Imaging Modalities in Estimating Myocardial Viability
Aug 6, 2025 · First-pass perfusion imaging in CMR assesses myocardial blood flow and identifies ischemic but viable myocardium prior to performing late ...
[131]
Myocardial Viability: Evolving Insights and Challenges in ... - NIH
Mar 20, 2025 · This narrative review explores the concept of myocardial viability, its assessment through contemporary imaging techniques, its clinical utility ...
[132]
Research Progress in Imaging Evaluation of Myocardial ... - NIH
Oct 3, 2025 · This review summarizes the principles, clinical applications, and recent research progress of these imaging modalities in evaluating myocardial ...
[133]
Guidelines for the Early Management of Patients With Acute ...
Oct 30, 2019 · Obtain a follow-up CT or MRI scan at 24 h after IV alteplase before starting anticoagulants or antiplatelet agents. AIS indicates acute ...
[134]
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after ...
May 8, 2019 · The time to initiate intravenous thrombolysis for acute ischemic stroke is generally limited to within 4.5 hours after the onset of symptoms.
[135]
Alteplase in an Extended Time Window for Ischemic Stroke
Sep 11, 2025 · Patients with acute stroke receiving alteplase 4.5 to 24 hours after symptom onset have better outcomes with alteplase than standard treatment, ...
[136]
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between ...
Nov 11, 2017 · The effect of endovascular thrombectomy that is performed more than 6 hours after the onset of ischemic stroke is uncertain.
[137]
Large Core Thrombectomy: Feasibility of Simplified Protocol in ...
Sep 23, 2025 · Endovascular thrombectomy (EVT) is the gold standard for treating selected patients with acute ischemic stroke caused by large vessel occlusions ...
[138]
Tenecteplase for Acute Ischemic Stroke at 4.5 to 24 Hours
Oct 13, 2025 · TNK improves excellent functional outcomes and recanalization in patients with acute ischemic stroke treated within 4.5 to 24 hours, without ...
[139]
Guidelines for the Early Management of Patients With Acute ...
AHA Guideline and Statements Hub content for 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke.
[140]
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the ...
Feb 27, 2025 · The 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes incorporates new evidence since the 2013 ACCF/AHA ...
[141]
Acute mesenteric ischemia: updated guidelines of the World Society ...
Oct 19, 2022 · AMI may be occlusive or non-occlusive (NOMI), with the primary etiology further defined as mesenteric arterial embolism (50%), mesenteric ...
[142]
Predicting Mortality in Patients Hospitalized With Acute Myocardial ...
Jan 13, 2025 · The overall in-hospital mortality rate was 5.0% (n=15 822 deaths). The final model included 14 variables, with out-of-hospital cardiac arrest, ...
[143]
Heart failure after myocardial infarction: incidence and predictors - NIH
The aim of the present paper was to provide an up‐to‐date view on epidemiology and risk factors of heart failure (HF) development after myocardial infarction.
[144]
Intra‐Arterial Thrombolysis After Successful Thrombectomy
Jul 31, 2025 · Meta‐analysis demonstrated that IAT following successful EVT improved the rate of disability‐free survival at 90 days, with a pooled risk ratio ...
[145]
Intra-Arterial Urokinase After Endovascular Reperfusion for Acute ...
Jan 13, 2025 · ... 90%-100% reperfusion of visible vessels) with thrombectomy, less than half of patients with stroke are disability-free at 90 days.
[146]
Effects of a Multimodal Management Strategy for Acute Mesenteric ...
Acute mesenteric ischemia (AMI) accounts for about 0.1% of hospital admissions and is associated with a daunting mortality rate of 60% to 80%.
[147]
Percutaneous thrombectomy for acute limb ischemia is associated ...
Jan 12, 2024 · Acute limb ischemia (ALI) carries a 15% to 20% risk of combined death or amputation at 30 days and 50% to 60% at 1 year.
[148]
High risk and low prevalence diseases: Acute limb ischemia
... amputation-free survival rates after hospital discharge, and acute limb ischemia continues to have a 30-day amputation rate of 10–30% and a mortality rate ...
[149]
Stroke and cognitive impairment: understanding the connection and ...
Studies have reported that cognitive impairment can occur in ~30–70% of stroke survivors4.<|control11|><|separator|>
[150]
Post-Stroke Neuropsychiatric Complications: Types, Pathogenesis ...
Depression is the most frequent post-stroke psychiatric disorder, with an estimated prevalence range from 18% to 33% [46, 47]. Patients who suffer post-stroke ...
[151]
Ischemic Cardiomyopathy - StatPearls - NCBI Bookshelf - NIH
Ischemic cardiomyopathy (ICM) is a term that refers to the heart's decreased ability to pump blood properly, due to myocardial damage brought upon by ischemia.
[152]
Arrhythmias After Acute Myocardial Infarction - PMC - NIH
Mar 31, 2023 · Risk factors associated with developing atrial fibrillation include advanced age, increased extent of myocardial damage, heart failure symptoms, ...<|control11|><|separator|>
[153]
Ischaemic stroke-induced distal organ damage - PubMed Central
Dec 18, 2020 · Acute ischaemic stroke is associated with a high risk of non-neurological complications, which include respiratory failure, cardiovascular ...
[154]
Quantifying Longevity After Myocardial Infarction: What Is Lost and ...
Sep 9, 2024 · Prior data in a US cohort of older Medicare patients from 1994 to 1995 found that patients lost ≈4.5 years of potential life after MI on average.
[155]
A systematic review and meta-analysis of clinical efficacy of early ...
Mar 8, 2024 · Early rehabilitation can significantly improve self-care abilities, daily activities, and neurological functions of ischemic stroke patients.Missing: myocardial | Show results with:myocardial<|separator|>
[156]
Global burden of ischaemic heart disease from 2022 to 2050
Jun 23, 2025 · By 2050, global IHD incidence, prevalence, deaths, and DALYs are projected to reach 67.3 million, 510 million, 16 million, and 302 million, respectively.
[157]
Historic review: select chapters of a history of stroke - PMC - NIH
Dec 1, 2020 · The history of stroke consists of two periods: the early era from the beginnings to 1812, and the following period from 1812 up to the present.
[158]
ECG diagnosis of acute ischaemia and infarction - Oxford Academic
Feb 22, 2006 · Einthoven used the device to record an ECG from a human, and published his findings between 1902 and 1903 in Dutch, English and German.<|separator|>
[159]
The history of cardiac catheterization - PubMed
The first right heart catheterization in a human was performed by Werner Forssmann on himself in 1929. Diagnostic cardiac catheterization was introduced by ...
[160]
A Randomized Trial of Intraarterial Treatment for Acute Ischemic ...
Dec 17, 2014 · Intraarterial treatment administered within 6 hours after stroke onset was effective and safe. (Funded by the Dutch Heart Foundation and others)
[161]
Application of Artificial Intelligence in Acute Ischemic Stroke
Feb 18, 2025 · This review examines 505 original studies on AI applications in ischemic stroke, categorized into outcome prediction, stroke risk prediction, diagnosis, ...
[162]
ischaemia noun - Definition, pictures, pronunciation and usage notes
Word Originlate 19th cent. (denoting the staunching of bleeding): modern Latin, from Greek iskhaimos 'stopping blood', from iskhein 'keep back' + haima 'blood'.Missing: ischai | Show results with:ischai
[163]
Pathophysiology of Reperfusion Injury - NCBI - NIH
Ischaemia-Reperfusion injury (IRI) is defined as the paradoxical exacerbation of cellular dysfunction and death, following restoration of blood flow to ...
[164]
Historical Perspective on the Pathology of Myocardial Ischemia ...
Aug 2, 2013 · Fully developed acute myocardial infarction was recognized at autopsy throughout the 19th and 20th century. Furthermore, many clinicians (eg ...<|separator|>